Glenmark Pharma launches TEVIMBRA in India
Glenmark Pharmaceuticals announced that it had launched TEVIMBRA (tislelizumab) in India after receiving approval from the Central Drugs Standard Control Organization (CDSCO). The drug is a specially designed anti-PD-1 monoclonal…
DCGI issues advisory against Digene Gel; raises safety concerns after Abbott’s voluntary recall
The Drugs Controller General of India has issued an advisory for patients and healthcare professionals to discontinue the use of popular antacid Digene gel due to safety concerns after drugmaker Abbott initiated a voluntary recall of…
DCGI Asks Manufacturers Not To Submit Same Batch Of Cough Syrup To More Than One Lab
New Delhi : The Drugs Controller General of India (DCGI) has directed the manufacturers not to submit the same batch of cough syrup to more than one laboratory at a time,…
FSSAI Cracks Down On Use Of Chemicals, Pesticides In Vegetables
NEW DELHI : The Food Safety Standards Authority of India (FSSAI) has directed all states and union territories to intensify surveillance of fresh produce due to mounting concerns over high concentrations…